Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
| Status: | Completed |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 11/8/2014 |
| Start Date: | August 2014 |
| End Date: | September 2014 |
| Contact: | Irene Mirkin, MD |
| Email: | participate@covance.com |
| Phone: | 1-800-732-2528 |
Pharmacokinetics and Metabolism of [14C] BMS-955176 in Healthy Male Subjects
The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and
extent of elimination, safety and tolerability of a single oral dose of [14C] BMS-955176 in
healthy male subjects. There is no formal research hypothesis to be statistically tested for
this study.
extent of elimination, safety and tolerability of a single oral dose of [14C] BMS-955176 in
healthy male subjects. There is no formal research hypothesis to be statistically tested for
this study.
Inclusion Criteria:
- Healthy Male subjects
- Ages 18-50 years
- Body weight of at least 110 lbs (50kg)
- BMI of 18 to 32 kg/m^2
- non-smoking
Exclusion Criteria:
- Clinically significant diagnostic or therapeutic radiation exposure within the
previous 12 months (eg serial X-ray or CAT scans, barium meals).
- gastrointestinal disease including gastrointestinal surgery
- constipation or irregular bowel movements
We found this trial at
1
site
Click here to add this to my saved trials
